PubMed Health⌕ Search

Biomedical subjects

F L Minnear

Publications and source records attributed to F L Minnear.

53 records · Page 3Linked to original sources

Comparison of alpha- and gamma-thrombin on lung fluid balance in anesthetized sheep.

We examined the effects of varying dosages of thrombin on lung fluid balance in halothane-anesthetized sheep prepared with lung lymph fistulas. A 15-min iv infusion of sublethal doses of alpha-thrombin (2.5 clotting units/micrograms), the native enzyme, at 0.6 or 1.1 nmol active enzyme/kg body wt increased the mean pulmonary arterial pressure (Ppa) and pulmonary vascular resistance (PVR) two- to threefold. Neither parameter increased in a dose-dependent manner. Platelet counts decreased 50% with both dosages. Leukocyte counts decreased 35 and 75% from base line in the low- and high-dosage groups, respectively, and reached comparable levels of 50% below base line at 60-min postinfusion in both groups. Plasma fibrinogen concentrations decreased in a dose-dependent manner preceding dose-dependent increases in pulmonary lymph flow (Qlym) and lymph protein clearance (Clym). Fibrin deposition in pulmonary vessels was greater at 30 than at 180 min postinfusion. In contrast, a 15-min iv infusion of gamma-thrombin (0.002 clotting units/micrograms), which lacks the fibrinogen recognition site, at 1.2 nmol active enzyme/kg produced no significant increases in PVR, Ppa, Qlym, or Clym. The fibrinogen concentration did not change significantly, whereas platelet and leukocyte counts decreased 25% within 15 min. Fibrin microthrombi were less prominent in pulmonary vessels. Fibrin deposition associated with intravascular coagulation may be an important factor mediating thrombin-induced increases in pulmonary transvascular fluid and protein exchange.

6-Ketoprostaglandin F1 alpha↗

Influence of plasma fibronectin on the response to infusion of thrombin and adenosine diphosphate.

An important physiological anti-thrombotic function has been suggested for plasma fibronectin and the reticuloendothelial system. The current study evaluated the effects of specific immunological fibronectin depletion and fibronectin supplementation upon resistance to infusion of thrombin and ADP in terms of mortality, mean arterial blood pressure and circulating levels of platelets, fibrinogen and fibrin degradation products. Mortality data indicated that rats with reduced fibronectin levels had reduced resistance to thrombin or adenosine diphosphate infusion. The increased lethality was characterized by reduced circulating levels of fibrinogen and platelets while fibrin degradation product levels rose. The infusion of ADP or thrombin in fibronectin supplemented rats failed to elicit higher mortality or reduce fibrinogen or platelet levels further. These data are consistent with the hypothesis that resistance to excessive coagulation and/or platelet aggregation is correlated to circulating plasma fibronectin levels. It is suggested that by direct effects and/or acting as an opsonin for RES phagocytosis, plasma fibronectin acts as an important anti-thrombotic mechanism.

Adenosine Diphosphate↗

Effects of transient intracranial hypertension on lung fluid and protein exchange.

We determined whether a transient increase in intracranial pressure (Pic) increases lung vascular permeability and whether the increase occurs at a Pic threshold. Anesthetized sheep were prepared with lung lymph fistulas. Pic was increased by rapidly injecting 20-45 ml of freshly drawn autologous blood into the cisterna magna from a base line of 4.8 +/- 1.5 Torr to a peak mean value of either 142.0 +/- 17.6 Torr (group I, n = 5) or 70.3 +/- 3.5 Torr (group II, n = 5). Pic decreased to 34.6 +/- 2.2 Torr in group I and to 31.0 +/- 3.2 Torr in group II within 1 h and remained steady at these levels for the study. The Cushing response (i.e., marked systemic hypertension lasting 10-15 min) was elicited only in group I; changes in mean pulmonary arterial (Ppa) and mean pulmonary arterial wedge (Ppw) pressures during the first 15 min were small, pulmonary blood flow (QL) increased, and pulmonary vascular resistance (PVR) decreased only in the first 15 min after the intracisternal injection. In group II, Ppa and QL did not change significantly, but PVR increased after the increase in Pic. Both pulmonary lymph flow (Qlym) and transvascular protein clearance (CL) increased only in sheep with the Cushing response. In group III (n = 8) in which Qlym and CL increased after intracranial hypertension as in group I, the left atrial pressure was raised to increase the pulmonary capillary pressure (Pc) to determine the basis for the increases in Qlym and CL (i.e., whether vascular surface area or permeability increased). The increase in Pc produced a small increase and decrease in lymph-to-plasma protein concentration ratio, indicating that the transient increase in Pic did not increase endothelial permeability to proteins. The increases in Qlym and CL were due to increased pulmonary vascular surface area.

Animals↗

Effects of cyclooxygenase and lipoxygenase inhibition on lung fluid balance after thrombin.

We examined the roles of the cyclooxygenase and lipoxygenase pathways in the alterations in lung fluid and protein exchange after pulmonary microembolism. Infusion of alpha-thrombin (T) (55 +/- 13 U/kg) immediately increased mean pulmonary arterial pressure (Ppa) and mean pulmonary vascular resistance (PVR), but both Ppa and PVR waned with time after T. Cyclooxygenase inhibition with either indomethacin or ketoprofen produced sustained increases in Ppa and PVR. The initial increases in Ppa in the cyclooxygenase-inhibited groups (CI) were matched to the control group by administering greater amounts of T. In the control group, T rapidly increased pulmonary lymph flow (Qlym) by two- to threefold, and this was associated with a steady increase in lymph-to-plasma protein concentration ratio (L/P). In contrast, in cyclooxygenase-inhibited (CI) groups, Qlym increased gradually to greater levels than in the control group, and L/P did not change. The effect on lung vascular permeability was determined by inflating a left atrial balloon catheter to raise pulmonary capillary pressure (Pc). An increase in Pc after T in the control group further increased Qlym and did not change L/P, whereas the increase in Pc after T in CI groups further increased Qlym and decreased L/P, indicating that cyclooxygenase inhibition prevented the increase in permeability. We determined whether lipoxygenase activation contributed to the increase in Qlym in CI groups by examining the effects of BW755C, an inhibitor of both cyclooxygenase and lipoxygenase pathways. BW755C resulted in the same increase in Qlym after T as in the control group, but the increase in Qlym was associated with a decrease in L/P. Therefore, inhibition of both pathways prevented the permeability increase and the greater increase in Qlym. The results indicate that cyclooxygenase and lipoxygenase pathways contribute to the increases in pulmonary transvascular fluid and protein fluxes after thrombin.

4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyraz↗

Effects of transient pulmonary hypertension on pulmonary vascular permeability.

The effects of a transient increase in pulmonary microvascular pressure (Pmv) on pulmonary fluid and protein exchange were studied in anesthetized sheep in which pulmonary lymph was collected. Pmv was increased to 30-40 mmHg for 15-30 min in 18 sheep by either an intra-aortic injection of norepinephrine (NE) or a rapid inflation of a left atrial balloon. NE injection produced sustained two- to threefold increases in pulmonary lymph flow and protein flux, whereas rapid balloon inflation transiently elevated lymph flow even though Pmv increased to similar levels with both methods. The sustained increases with NE were not due to an increase in vascular permeability but probably the result of a persistent increase in vascular surface area. In three additional animals, Pmv was increased to over 50 mmHg for 15-30 min. In these animals, lymph flow increased only by 49%, but airway edema fluid was present. The ratio of extravascular lung water to bloodless dry lung weight was 5.77 +/- 0.13 as compared with 4.30 +/- 0.11 in sheep subjected to Pmv less than 50 mmHg and to 4.08 +/- 0.19 for controls. These findings indicate that high pressure-induced pulmonary edema depends on a threshold Pmv around 50 mmHg. A combination of high capillary pressure and impaired lymphatic flow may be the bases for the development of neurogenic and catecholamine-induced pulmonary edema.

Animals↗

Effect of bradykinin on lung vascular permeability in sheep.

Bradykinin (BK, 0.03-3.11 micrograms X kg-1 X min-1) was infused intravenously for 4-5.5 h to assess its effects on pulmonary transvascular fluid and protein exchange in three groups of artificially ventilated sheep prepared with lung lymph fistulas. In group I, BK was infused alone for 5.5 h. In group II, BK and captopril (SQ 14,225), an inhibitor of angiotensin-converting enzyme (ACE), were infused together because the effects of BK may be attenuated by its rapid degradation in the lung by ACE. In group III, BK was infused in the presence of propranolol, a beta-adrenergic antagonist, to prevent any permeability-decreasing effects of beta-adrenergic activation. The dosages of BK used, which decreased systemic arterial blood pressure by 10-20 mmHg, did not alter either pulmonary transvascular fluid and protein exchange or pulmonary hemodynamics at any time during infusion of BK alone or in combination with captopril or propranolol. Raising pulmonary microvascular pressure (Pmv) by inflating a left atrial balloon during the last 2 h of infusion in all three groups slightly increased pulmonary lymph flow and markedly decreased the lymph-to-plasma protein concentration ratio. These results are comparable with those obtained after increasing Pmv in normal anesthetized sheep and indicate that BK did not alter the pulmonary vascular permeability to proteins.

Angiotensin-Converting Enzyme Inhibitors↗

Prevention of aconitine-induced neurogenic pulmonary edema (NPE) with hypovolemia or methylprednisolone.

Bilateral injections of aconitine in the preoptic-anterior hypothalamic area in rats produces pulmonary edema that is mediated by neurogenic mechanisms. The aim of the present study was to determine the efficacy of hypovolemia or intravenous methylprednisolone on preventing aconitine-induced pulmonary edema. Rats made hypovolemic before or after injection of aconitine or treated with 40 mg/kg methylprednisolone had normal lung weight-to-body weight ratios (LW/BW) and normal pulmonary ultrastructure. In contrast, high LW/BW and gross ultrastructural alterations were noted in rats injected with aconitine only. These findings suggest that hypovolemia was effective in preventing aconitine-induced neurogenic pulmonary edema (NPE) because it lowered the pulmonary blood volume and that methylprednisolone provided a beneficial effect by suppressing the hemodynamic response involved in NPE or by directly stabilizing the cell membranes.

Aconitine↗

Effect of ADP-induced platelet aggregation on lung fluid balance in sheep.

The effects of platelet aggregation (PA), induced by an intravenous injection of adenosine 5'-diphosphate (ADP), on pulmonary fluid and protein exchange and on arterial blood gases were determined in artificially ventilated sheep prepared with lung lymph fistulas. ADP injection produced small increases (P less than 0.01) in pulmonary lymph flow (Qlym) and transvascular protein clearance (Qlym X lymph-to-plasma protein concentration ratio). These changes were not associated with significant increases in pulmonary arterial and left atrial pressures, pulmonary blood flow, or pulmonary vascular resistance. ADP-induced PA did not increase the pulmonary endothelial permeability to proteins, because an elevation of pulmonary microvascular pressure (Pmv), induced by inflation of a left atrial balloon catheter, produced the same increases in Qlym and protein clearance as in normal sheep after comparable increases in Pmv. The increases in Qlym and protein clearance can be explained by an increase in pulmonary vascular surface area. ADP-induced PA decreased the arterial oxygen tension, which was sustained for the 3 h duration of the study; the arterial carbon dioxide tension did not change and the arterial pH decreased (P less than 0.05) after PA. Chronic depletion of platelets with antiplatelet serum prevented the increases in Qlym and protein clearance and the arterial hypoxemia, indicating that these changes were the direct result of PA. Thus ADP-induced PA in sheep increased pulmonary fluid filtration and protein clearance by an increase in the vascular surface area. Also PA produced a rapid and prolonged arterial hypoxemia, which may result from the release of vasoactive and bronchoactive factors causing a maldistribution of ventilation and perfusion.

Adenosine Diphosphate↗

Effects of epinephrine and norepinephrine infusion on lung fluid balance in sheep.

The effect of an intravenous infusion of epinephrine or norepinephrine (45 microgram.kg-1.min-1) on the transcapillary exchange of fluid and protein were studied in anesthetized sheep prepared with lung lymph fistulas. After infusion of epinephrine, pulmonary lymph flow (Qlym) and the ratio of lymph to plasma protein concentration (L/P) did not change significantly from base line despite an increase in mean pulmonary arterial pressure (Ppa) from 17.3 +/- 0.8 to 22.6 +/- 0.09 Torr, In contrast, Qlym increased (p less than 0.05) from 9.24 +/- 1.53 to 11.46 +/- 1.97 ml/h and L/P decreased (p less than 0.05) from 0.78 +/- 0.03 to 0.74 +/- 0.04 after infusion of norepinephrine; these changes were associated with an increase in Ppa from 16.5 +/- 1.5 to 21.6 +/- 1.8 Torr. Pulmonary vascular resistance (PVR) increased from 5.90 +/- 0.83 to 12.12 +/- 1.23 Torr. 1-1 min (p less than 0-.01) after epinephrine and from 6.52 +/- 0.82 to 9.26 +/- 1.74 Torr.1-1 min (p less than 0.05) after norepinephrine. Left atrial hypertension, induced in four sheep infused with norepinephrine and in five sheep infused with epinephrine by inflating a left atrial balloon, increased Qlym and decreased L/P in all animals. Thus the infusions of epinephrine or norepinephrine did not increase lung vascular permeability to proteins. Epinephrine infusion also did not increase fluid filtration despite increases in Ppa and PVR, suggesting that pulmonary microvascular pressure did not increase significantly due to greater constriction of precapillary than postcapillary vessels. However, norepinephrine infusion increased filtration, suggesting that microvascular pressure was increased due to a greater constriction of postcapillary than precapillary vessels.

Animals↗

Lung fluid and protein exchange in the acute sheep preparation.

We examined the effect of left atrial hypertension on lung fluid and protein exchange in acutely prepared anesthetized sheep. The results were compared with those reported by Erdmann jet al. (Circ. Res. 37:271-284, 1975) in chronically instrumented conscious sheep. Animals were anesthetized with halothane and efferent duct of the caudal mediastinal node was cannulated. Pulmonary microvascular pressure (Pmv) was elevated by raising left atrial pressure with a left atrial balloon. For every elevation in Pmv of 1 cmH2O pulmonary lymph flow (Qlym) increased by 0.5 ml/h. Increasing the Pmv resulted in a linear decrease (p less than 0.05) in the ratio of lymph to plasma protein concentration as a result of a significant reduction in lymph protein concentration. Transvascular clearance of lymph proteins increased by 39% with a doubling of Qlym. The steady-state changes in pulmonary fluid and protein exchange induced by an increase in Pmv in acutely prepared anesthetized sheep were the same as those observed by Erdmann et al. in chronically instrumented unanesthetized sheep, indicating that the acute preparation is equally reactive to increase in Pmv and that the lung endothelial permeability is not increased.

Animals↗

Adrenoceptor control of lung fluid and protein exchange.

We studied the effects of alpha- and beta-adrenergic antagonists on lung fluid and protein exchange in anesthetized sheep. alpha-Adrenergic blockade with 2 mg/kg phentolamine caused a transient and small decrease in lung lymph flow (Qlym), which was associated with a decrease in mean pulmonary arterial pressure (Ppa); but the steady-state Qlym and mean left atrial pressure were not different from base-line values. In contrast, beta-adrenergic blockade with propranolol (2 mg/kg) caused an increase in Qlym from a base-line value of 7.7 +/- 2.2 ml/h to a steady-state value of 10.6 +/-2.3 ml/h within 2 h (P less than 0.05), which was not associated with a change in Ppa. The increase in Qlym persisted for the 4-h duration of the study. The 39% increase in Qlym after propranolol was associated with a 50% increase in transvascular protein clearance (CL), whereas in control animals the 100% increase in Qlym after left atrial hypertension was associated with only a 36% increase in CL, indicating increased transvascular transport of proteins after propranolol. The transient decrease in Qlym after phentolamine may be due to the short-lasting decreased in pulmonary microvascular pressure and vascular surface area. However, the long-lasting increases in Qlym and CL after propranolol may be due to an increase in vascular surface area and to an increase in endothelial permeability of proteins. The results suggests that beta-adrenergic receptors regulate the transendothelial transport of fluid and proteins.

Animals↗

Effect of acute pancreatitis on pulmonary transvascular fluid and protein exchange.

We used the anesthetized sheep lung lymph preparation to examine the effects of acute hemorrhagic pancreatitis on pulmonary transvascular fluid and protein exchange. Induction of acute pancreatitis by injection of trypsin and sodium taurocholate into the pancreatic duct caused significant increases (p less than 0.05) in lung lymph flow, ratio of lymph to plasma protein concentration (L/P ratio), and transvascular protein clearance. Pulmonary arterial and pulmonary arterial wedge pressures did not change significantly, but pulmonary blood flow decreased (p less than 0.05) and pulmonary vascular resistance increased (p less than 0.05). In contrast to the effects of acute pancreatitis, left atrial hypertension caused increases in lung lymph flow that were associated with decreases in the L/P ratio. Extravascular lung water content was increased after acute pancreatitis by 25% from the value obtained in sham-operated animals in which saline was injected into the pancreatic duct. These findings indicate that acute hemorrhagic pancreatitis causes an increase in pulmonary vascular permeability to proteins. Because pulmonary vascular pressures did not change, the increased permeability may be due to the cellular and humoral factors rather than hemodynamic mechanisms.

Acute Disease↗

Increased pulmonary vascular permeability after bone marrow injection in sheep.

We determined the effects of injection of bone marrow into the pulmonary circulation on pulmonary fluid and protein exchange in sheep. We also assessed the roles of free fatty acid toxicity and secondary thrombosis as mediators of the changes in pulmonary fluid balance. Injection of small amounts of bone marrow (range 0.07 to 0.41 ml/kg) resulted in pulmonary edema associated with increases in steady-state pulmonary lymph flow and protein clearance that the characteristic of increased endothelial permeability. There was no change in plasma concentrations of free fatty acids after injection. The small increases in lymph fatty acid clearance paralleled the increases in lymph protein clearance, reflecting the rapid binding of fatty acids to albumin. Decreased plasma fibrinogen with a concomitant increase in fibrin degradation products followed the bone marrow injection, indicating the activation of intravascular coagulation. In addition, the leukocyte count rapidly decreased just after the bone marrow injection. These findings suggest that the increased permeability was due to intravascular coagulation and resultant fibrin entrapment and leukostasis, and was not a result of increased circulating fatty acids.

Albumins↗